The 1st clinical review of the ACURATE neo2 Aortic Valve System with new Active PVseal™ sealing technology.
STUDY DESIGN: N=120; European, prospective, single arm, multicenter study
PVL at 7 Days/Discharge, 30 Days, and 1 year1
PRospective Observation of aortic reGuRgitation aftEr TAVI and progreSS over time (PROGRESS) PVL registry.
STUDY DESIGN: N=500; open-label, single arm, multicenter registry at 22 centers in
Germany, Canada, the United Kingdom, and Italy
PVL, Paired Analysis
Largest series, all-comers experience of ACURATE neo™ Aortic Valve System
STUDY DESIGN: N = 1,000; Real-world, European, prospective, single-arm, multicenter, all-comers registry